ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

REVB Revelation Biosciences Inc

2.21
-0.05 (-2.21%)
Jun 14 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 72,595
Bid Price 2.10
Ask Price 5.00
News -
Day High 2.38

Low
1.61

52 Week Range

High
35.40

Day Low 2.17
Share Name Share Symbol Market Stock Type
Revelation Biosciences Inc REVB NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
-0.05 -2.21% 2.21 23:00:06
Open Price Low Price High Price Close Price Previous Close
2.35 2.17 2.38 2.21 2.26
Trades Shares Traded VWAP Financial Volume Average Volume 52 Week Range
605 72,595 US$ 2.34 US$ 169,874 - 1.61 - 35.40
Last Trade Type Quantity Price Currency
17:06:07 2 US$ 2.10 USD

Revelation Biosciences Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
2.1k 209.91k - 0 -120k -0.57 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Revelation Biosciences News

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No REVB Message Board. Create One! See More Posts on REVB Message Board See More Message Board Posts

Historical REVB Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week2.172.47991.812.2634,6390.041.84%
1 Month1.832.47991.612.0543,9160.3820.77%
3 Months2.402.961.612.2449,910-0.19-7.92%
6 Months16.2025.261.616.93266,671-13.99-86.36%
1 Year33.0035.401.6111.07175,137-30.79-93.30%
3 Years8,799.0010,237.501.61980.141,208,508-8,796.79-99.97%
5 Years8,799.0010,237.501.61980.141,208,508-8,796.79-99.97%

Revelation Biosciences Description

Revelation Biosciences Inc is a clinical-stage life sciences company focused on the development of immunologic-based therapies for the prevention and treatment of disease. It has several product candidates in development. REVTx-99, the lead therapeutic candidate, is an intranasal immunomodulator to prevent or treat infections caused by various respiratory viruses such as SARS-CoV-2, including its variants, influenza A and B, parainfluenza, rhinovirus, and RSV. REVTx-99 is also being developed for other indications such as: allergic rhinitis and chronic nasal congestion. REVTx-200 is an intranasal immunomodulator adjunct to be used in combination with an intramuscular vaccination for more complete immunity. REVTx-200 is based on the same technology used in REVTx-99.

Your Recent History

Delayed Upgrade Clock